Please assess the completion status of the following clinical trial:

Trial Title: Pramlintide in Adolescents With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Between 13 and 17 years of age, inclusive~* Diagnosed with type 1 diabetes for \> 1 year~* Hemoglobin A1c between 7.5 and 10% inclusive~* Currently using carbohydrate to insulin ratio~* Acceptable form of birth control~Exclusion Criteria:~* Use of oral hyperglycemic agents or medications affecting blood sugar levels~* Recurrent severe hypoglycemia requiring assistance in past 6 months~* History of hypoglycemia unawareness~* History of gastroparesis requiring use of drugs that stimulate gastrointestinal motility~* Previous use of pramlintide

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- 1 Symlin (Type: EXPERIMENTAL): Subcutaneous injection of pramlintide prior to each meal with reduction of mealtime bolus insulin
- 2 Usual Regimen (Type: NO_INTERVENTION): Usual bolus insulin dose at each meal

Based on this trial design, predict the completion outcome and termination type (if applicable).